Skip to content

ENDS IN 21 MONTHS

Cder Streamline Process And Enhance Functions For New Drug Review

Food and Drug Administration · FDA OFFICE OF ACQ GRANT SVCS

Sign in to track this contract

CAN YOU BID THIS?

8(a) sole source

  • Last award was an 8(a) sole-source. The agency can award it directly to an 8(a) firm again; the path in is marketing your 8(a) firm to this office before it decides.

Sign in and add a company profile to get a call for your firm.

Pro adds how many offers it drew last time to this read.

Check before you spend bid hours

  • The next option decision is due by Jul 31, 2027. If the agency declines it, the recompete comes sooner than Jul 31, 2028.
  • This is an order under 47QTCA18D0071. The vehicle itself may end, be replaced, or have its ordering period extended; check its status too.
  • Dates and values are from USAspending as of Oct 20, 2026. Confirm the incumbent's end date with the contracting office or a Sources Sought before committing bid hours.
Incumbent
AGISOL LLC
Small business · UEI G86VNCELJ5R3
Recompete expected (last option ends)
Jul 31, 2028
Current option period ends
Jul 31, 2027
Potential value
$4.1M ($3.0M obligated)
NAICS
541519 · Other Computer Related Services
PSC
B537 · Special Studies/Analysis- Medical/Health
Set-aside
8(A) Sole Source
Vehicle
Order under 47QTCA18D0071
Award type
Delivery Order
Place of performance
MD
Solicitation ID
—
PIID
75F40123F80143

Last competition, subcontractors and incumbent

See how many offers this contract drew last time, who the incumbent subcontracts to, and the rest of the incumbent's expiring portfolio.

Unlock with Pro — $39 / mo

The buying office on SAM.gov

From notices this office (75F401) posted on SAM.gov in the last 12 months. Contacts are the duty points of contact published on those notices. All recompetes and contacts for this office →

Recent notices from this office (1)

More expiring contracts from this office

Source: USAspending.gov prime award summary (FPDS), last modified Jul 13, 2026. Periods of performance change when options are exercised or the contract is modified; confirm on the source record before acting.